Company:
At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.
For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA.
We seek applicants from all backgrounds to ensure we get the best, most creative talent on our team. We are building a diverse and inclusive workforce – come and be a part of our growth.
At Annexon, we are building a diverse, equitable, inclusive, and innovative company and we are looking for the BEST candidate for the job. That candidate may come from a less traditional background or may meet the qualifications in a different way. We would strongly encourage you to apply – especially if the reason you are the best candidate is not exactly as we describe it here. Learn more about Annexon’s commitment to diversity, equity, inclusion our values and culture!
Position:
The Executive Director, Marketing will lead the development and execution of marketing strategies targeted at healthcare professionals. This role is critical in driving awareness, adoption, and advocacy of Annexon’s therapies among key healthcare stakeholders. The position requires a strategic marketer with deep experience in the biotech or pharmaceutical industry, particularly in HCP engagement and education.
Responsibilities include:
- Develop and execute a comprehensive HCP marketing strategy that aligns with the company’s overall marketing and business goals.
- Lead the creation, implementation, and optimization of multi-channel marketing campaigns targeting healthcare professionals, including digital, print, and in-person initiatives.
- Drive engagement with key healthcare professionals through educational programs, thought leader collaborations, advisory boards, and medical conferences.
- Oversee the creation of compelling and compliant marketing content for HCPs, including promotional materials, educational resources, and digital assets.
- Build and maintain relationships with key opinion leaders (KOLs) and other influential healthcare professionals to drive advocacy and support for Annexon’s therapies.
- Work closely with cross-functional teams, including Medical Affairs, Sales, and Market Access, to ensure alignment of HCP marketing strategies with broader commercial objectives.
- Utilize market research and analytics to inform marketing strategies, understand HCP needs, and measure the effectiveness of campaigns.
- Ensure all HCP marketing activities comply with relevant regulations and industry standards, including promotional guidelines and company policies.
- Manage the HCP marketing budget, ensuring efficient allocation of resources to achieve strategic objectives.
- Build, mentor, and lead a team of marketing professionals focused on HCP engagement, fostering a culture of innovation and excellence.
Education, Experience, and Skills:
Required:
- Bachelor’s degree in Marketing, Communications, Life Sciences, or a related field.
- A minimum of 12+ years of experience in biotech or pharmaceutical industry, with at least 5 years in HCP Marketing role.
- Deep knowledge of HCP marketing, including strategies for engagement, education, and KOL management.
- Strong understanding of regulatory requirements related to HCP marketing in the biotech/pharma industry.
- Excellent leadership and team management skills.
- Strong strategic thinking and problem-solving abilities.
- Outstanding communication and relationship-building skills.
- Proficiency in marketing tools and technologies, including CRM and analytics platforms.
Preferred:
- An advanced degree (e.g., MBA, MPH) is preferred.
- Experience with specialty and rare disease therapies is highly desirable.
Salary Range: $249,000 to $300,000
Benefits:
- A stimulating and rewarding workplace includes flexible work schedules, remote opportunities and the ability to achieve a work-life balance.
- We are located in Brisbane, CA, with shuttle service from BART, CalTrain and the Ferry.
- Annexon offers a competitive base salary and equity participation, employee stock purchase plan, as well as a comprehensive health benefit package that includes medical, dental, vision, 401(k), flexible spending plans, as well as other benefits.
Annexon Biosciences is an Equal Opportunity Employer, and we prohibit discrimination or harassment of any kind. We are committed to fostering an environment where ALL people are welcome and supported. We cultivate a culture of inclusion for all employees that respects their individual strengths, views, and experiences. We believe that our differences enable us to be a better team – one that makes better decisions, drives innovation, and delivers better business results. Creativity and innovation flourish in an environment of openness, inclusion, and mutual respect.
Staffing Agencies: Annexon Biosciences does not accept unsolicited agency resumes and will not pay fees to any third-party agency or firm that doesn’t have a signed agreement with Annexon Biosciences. Please do not send agency CVs/resumes through Annexon’s website or Annexon Employees. Inquiries must be sent to [email protected] with the Subject: Staffing Agency Request.
What We Do
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.